Abingdon Health Plc (LON:ABDX – Get Free Report) fell 2.6% on Thursday . The company traded as low as GBX 9.50 and last traded at GBX 9.50. Approximately 5,535 shares were traded during mid-day trading, a decline of 98% from the average session volume of 281,822 shares. The stock had previously closed at GBX 9.75.
Abingdon Health Stock Performance
The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The company’s 50-day moving average price is GBX 11.24 and its two-hundred day moving average price is GBX 8.80. The company has a market cap of £24.48 million, a P/E ratio of -12.04 and a beta of 0.16.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Recommended Stories
- Five stocks we like better than Abingdon Health
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
